Company intelligence / Profile preview
Shihuida Pharmaceutical Group
Baishan or Jilin Province HQ in Shanghai per some listings, Jilin Sheng, Chinashihuidapharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shihuida Pharmaceutical Group has a pipeline focused on cardiovascular and oncology indications. Its lead small molecule combination drug "levamlodipine/bisoprolol" targets essential hypertension and has reached the NDA/BLA regulatory submission stage in China. The company also develops innovative biologics such as a recombinant anti-EGFR/IL‑10R bispecific FC fusion protein for malignant ascites, which has reached IND approval. Clinical trial activity includes at least ten registered studies.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Small moleculeRecombinant fusion proteinMonoclonal antibody fragment (bispecific fusion protein)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shihuida Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shihuida Pharmaceutical Group.